Pfizer to seek vaccine approval in November

Daniel Fowler
October 17, 2020

China launched a vaccine emergency use programme in July, offering three experimental shots developed by a unit of state pharmaceutical giant China National Pharmaceutical Group and US-listed Sinovac Biotech.

The race to get a vaccine against Covid-19 won a new strong candidate, according to a statement from Lancet magazine released on Thursday (15).

What's more, the company will also gather manufacturing data to demonstrate "the quality and consistency of the vaccine that will be produced", Bourla said.

Bourla said Pfizer could know whether the vaccine is effective by the end of October, and that it is likely obtain the required safety data by the third week of November.

There are four vaccines in clinical trials in the US, and Shah said Thursday that each is different.

"We believe these are very conservative projections and see the potential to produce 10 million doses of vaccines in December", a spokesman for RDIF said.

China's Xi Jinping Asks Troops To Focus On "Preparing For War"
The Trump administration informed Congress of its plan to sell three advanced weapons to Taiwan, CNN reported Monday. We hope that we have succeeded by giving you the full details and information.

He described the offer as a response to popular demand: 'Some colleagues from the United Nations have asked about this, and we will not remain indifferent to them'. This would allow the companies to file for an emergency use authorization. "It has said that it may have interim data on its 30,000 person trial as soon as November", as reported by Reuters.

The announcement may be a disappointment to President Donald Trump, who has been raising expectations that vaccines could be ready around the time of the November 3 presidential election in an apparent bid to boost his faltering electoral prospects. In October, "the truth will be revealed", was what he told The Washington Post.

Maduro also said that his son and sister would take part in clinical trials of the vaccine, he himself would be vaccinated at the start of mass vaccination. And that information will be ready before the safety readout, he said.

Vektor is a former Soviet bioweapons research lab and, in addition to the U.S. Centers for Disease Control and Prevention, is one of two sites in the world that house smallpox stockpiles.

Polls show many Americans are hesitant about taking a coronavirus vaccine and concerned that the approval process could be driven by politics.

Speaking at this year's U.N. General Assembly, Putin offered to provide the Sputnik-V vaccine to U.N. staff for free.

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER